Champions Oncology Participates in Pre-Clinical Studies to Identify Novel Therapy for Childhood Cancer

Stock Information for Champions Oncology Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Champions Oncology Inc.

Champions Oncology Reports Quarterly Revenue of $12.0 Million
Champions Oncology's US Laboratory has Acquired Distinguished CAP Accreditation
Champions Oncology to Announce Third Quarter Financial Results on Tuesday, March 12, 2024
Champions Oncology Reports Quarterly Revenue of $11.6 Million
Champions Oncology to Announce Second Quarter Financial Results on Tuesday, December 12, 2023
Champions Oncology's European Research Operations Site Receives ISO-9001:2015 Accreditation and ATS Certification
Champions Oncology Announces the Addition of Brady Davis as President
Champions Oncology Reports Quarterly Revenue of $12.6 Million

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.